CytoSorbents Shares Rose 34% on Oct. 16 Ahead of Nasdaq Deadline

CytoSorbents shares jumped 34.31% on Oct. 16, but the close remained below the post-split Sept. 8 level as the company works to satisfy a separate Nasdaq market-value requirement. The shares finished regular trading at $4.11, up $1.05 from the previous session’s $3.06 close. They traded between $3.01 and $4.60 during the session. The Oct. 16 close was below the $6.85 split-adjusted close on Sept. 8, when CytoSorbents carried out a 1-for-20 reverse stock split. The comparison uses split-adjusted prices. CytoSorbents regained compliance with Nasdaq’s $1 minimum bid-price rule on Sept. 22.

Source: TokenPost